China Infectious Disease Diagnostics Market (2025-2030)
The China Infectious Disease Diagnostics Market was valued at $1243.3 Million in 2025 and projected to reach to $2249.6 Million by 2030, representing a compound annual growth rate of 12.6%. China's infectious disease diagnostics market is positioned for sustained growth through 2030, driven by escalating infectious disease prevalence, government healthcare reforms, and substantial increases in diagnostic spending.
China Infectious Disease Diagnostics Market Trends and Insights
- This represents a compound annual growth rate of 12.6%, significantly outpacing global market growth of 9.7%.
- China's market momentum is driven by rising infectious disease prevalence, increased healthcare spending, and rapid adoption of advanced diagnostic technologies across urban and rural regions. The Chinese market benefits from government initiatives promoting early disease detection and prevention, coupled with expanding laboratory infrastructure and point-of-care testing capabilities.
- China's substantial population base and growing middle class are accelerating demand for rapid, accurate diagnostic solutions.
- Between 2025 and 2030, China is expected to consolidate its position as a critical growth engine within the Asia Pacific infectious disease diagnostics sector, supported by technological innovation and regulatory support for diagnostic innovation..
Key Market Statistics
- CAGR (2025-2030) 12.6% CAGR
- Market Size, 2025 ~USD 1243.3 Million
- Forecast, 2030 ~USD 2249.6 Million
- Country China
China Infectious Disease Diagnostics Market Overview
Rapid Market Expansion :
China's infectious disease diagnostics market is growing at 12.6% CAGR, significantly outpacing the global rate of 9.7%, driven by increasing disease prevalence and healthcare modernization initiatives.
Substantial Market Valuation :
The market is valued at USD 1,243.3 million in 2025 and is projected to nearly double to USD 2,249.6 million by 2030, reflecting strong investment in diagnostic infrastructure.
Healthcare Spending Growth :
Rising government healthcare expenditure and increased private sector investment in diagnostic technologies are accelerating market adoption across urban and emerging healthcare facilities in China.
Technology Adoption Acceleration :
Rapid adoption of advanced diagnostic technologies, including molecular testing and point-of-care diagnostics, is transforming China's infectious disease detection capabilities and clinical outcomes.
China Infectious Disease Diagnostics Market Dynamics
- The market's 12.6% CAGR reflects strong demand for advanced testing solutions across hospitals, clinics, and laboratories nationwide. Key growth catalysts include expanding healthcare infrastructure in tier-2 and tier-3 cities, increasing awareness of early disease detection, and technological innovations in rapid diagnostics.
- Strategic investments by both domestic and international players are enhancing market penetration, while regulatory improvements continue to streamline product approvals and market entry, positioning China as a critical growth engine for global infectious disease diagnostics..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- China's infectious disease diagnostics market will grow from USD 1,243.3M (2025) to USD 2,249.6M (2030) at a 12.6% CAGR, outpacing global growth.
- Government healthcare initiatives and expanded laboratory infrastructure are primary catalysts driving China's market acceleration through 2030.
- China's large population and rising healthcare expenditure create sustained demand for rapid diagnostic and point-of-care testing solutions.
- China is positioned as the fastest-growing infectious disease diagnostics market in Asia Pacific, attracting significant investment and innovation.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
China Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need China-specific market data to assess market potential, identify growth segments, and develop localized product strategies for this rapidly expanding diagnostic market.
- Healthcare Investors & PE Firms : Investors require detailed market forecasts and growth drivers for China to evaluate investment opportunities, assess portfolio companies, and identify acquisition targets in the diagnostics sector.
- Hospital & Laboratory Networks : Healthcare facility operators need market insights to benchmark diagnostic capabilities, plan technology investments, and optimize procurement strategies aligned with market trends.
- Pharmaceutical & Biotech Companies : Companies developing infectious disease treatments require market data to understand diagnostic adoption rates and identify partnership opportunities with diagnostic providers in China.
- Healthcare Consultants & Advisors : Consultants need comprehensive China market analysis to advise clients on market entry strategies, competitive positioning, and growth opportunities in the infectious disease diagnostics sector.
Key Companies in the China Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for China (USD 1,243.3M in 2025) with detailed 5-year forecasts to validate investment decisions and competitive positioning strategies.
- Competitive Landscape Intelligence : Understand China-specific market dynamics, key players, and competitive strategies to identify partnership opportunities and market entry points in this high-growth region.
- Segment & Technology Insights : Access detailed breakdowns of diagnostic technologies, disease segments, and end-user categories specific to China's market to optimize product development and marketing strategies.
- Regional Growth Drivers : Identify China-specific growth catalysts including healthcare spending trends, regulatory environment, and technology adoption patterns to inform strategic planning and resource allocation.
- Risk & Opportunity Assessment : Evaluate market risks, regulatory challenges, and emerging opportunities unique to China's healthcare landscape to mitigate investment risks and capitalize on growth potential.
Frequently asked questions
What is the projected market size of infectious disease diagnostics in China by 2030?
China's infectious disease diagnostics market is projected to reach USD 2,249.6 million by 2030, up from USD 1,243.3 million in 2025.
What is the CAGR for China's infectious disease diagnostics market?
China's infectious disease diagnostics market is expected to grow at a compound annual growth rate of 12.6% between 2025 and 2030.
What factors are driving growth in China's infectious disease diagnostics market?
Key growth drivers in China include rising infectious disease prevalence, increased government healthcare spending, expanding laboratory infrastructure, and growing adoption of point-of-care testing technologies.
How does China's market growth compare to global infectious disease diagnostics growth?
China's 12.6% CAGR significantly exceeds the global market CAGR of 9.7%, positioning China as a high-growth region within the infectious disease diagnostics sector.
What role does China play in the Asia Pacific infectious disease diagnostics market?
China is the fastest-growing market in Asia Pacific for infectious disease diagnostics, serving as a critical growth engine and attracting substantial investment and technological innovation.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report